small profit taking atm.. rerate in process.. shorts have to cover.. final trial results due within the month and will confirm commercial rollout. This has derisked substantially and still sitting at prices post the TEVA disaster.. Where are those that said Teva walked because of insight into poor results, rather than their own cashflow problems? Looks like you were WRONG and we got handed the keys to the castle for FREE.
Ann: MSB Enters Into Cardiovascular Alliance For China With Tasly, page-182
-
- There are more pages in this discussion • 111 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |